Selectivity of recognition of variable (V) regions of autoantibodies by intravenous immunoglobulin (IVIg).

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Clinical Immunology and Immunopathology

• Publication date

  1994-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1006/CLIN.1994.1019PMID 8299227
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intravenous Immunoglobulin Therapy of Autoimmune and Systemic Inflammatory Diseases

  1993cited by this paper
• Are lymphocytes concerned with our definition of idiotypes?

  1993cited by this paper
• Origin of anti-idiotypic activity against anti-factor VIII autoantibodies in pools of normal human immunoglobulin G (IVIg).

  1992cited by this paper
• Human autoantibodies reactive with synthetic autoantigens from T-cell receptor beta chain.

  1992cited by this paper
• Manipulating the immune system with immune globulin.

  1992cited by this paper
• A V region‐connected autoreactive subfraction of normal human serum immunoglobulin G

  1992cited by this paper
• Treatment of systemic vasculitis with pooled intravenous immunoglobulin.

  1991cited by this paper
• Anti‐idiotypes against anti‐neutrophil cytoplasmic antigen autoantibodies in normal human polyspecific IgG for therapeutic use and in the remission sera of patients with systemic vasculitis

  1991cited by this paper
• A monoclonal anti-idiotypic antibody against the antigen-combining site of anti-factor VIII autoantibodies defines and idiotope that is recognized by normal human polyspecific immunoglobulins for therapeutic use (IVIg).

  1990cited by this paper
• Normal immunoglobulin G (IgG) for therapeutic use (intravenous Ig) contain antiidiotypic specificities against an immunodominant, disease-associated, cross-reactive idiotype of human anti-thyroglobulin autoantibodies.

  1990cited by this paper
• On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy.

  1990cited by this paper
• Antiidiotypes against autoantibodies in pooled normal human polyspecific Ig.

  1989cited by this paper
• Anti‐idiotypes against Autoantibodies in Normal Immunoglobulins: Evidence for Network Regulation of Human Autoimmune Responses

  1989cited by this paper
• Anti-idiotypes against autoantibodies and alloantibodies to VIII:C (anti-haemophilic factor) are present in therapeutic polyspecific normal immunoglobulins.

  1988cited by this paper
• Treatment of antibody-mediated pure red-cell aplasia with high-dose intravenous gamma globulin.

  1987cited by this paper
• Recovery from anti-VIII:C (antihemophilic factor) autoimmune disease is dependent on generation of antiidiotypes against anti-VIII:C autoantibodies.

  1987cited by this paper
• Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gammaglobulin.

  1984cited by this paper
• The 1982 revised criteria for the classification of systemic lupus erythematosus.

  1982cited by this paper

• Anti-SRP immune-mediated necrotizing myopathy responsive to ofatumumab: a case report

  2023cites this paper
• Targeted Therapies for Autoimmune Bullous Diseases: Current Status

  2018cites this paper
• Role of Intravenous Immunoglobulin in Dermatologic Disorders

  2018cites this paper
• Immune aregenerative anemia without erythroblastopenia: a previously undescribed condition

  2013cites this paper
• Identification of target antigens of self‐reactive IgG in intravenous immunoglobulin preparations

  2009cites this paper
• Using B Cell Characteristics as Predictors of Multiple Sclerosis in Clinically Isolated Syndrome Patients

  2009cites this paper
• Utilisation thérapeutique des immunoglobulines polyvalentes en hématologie

  2006cites this paper
• IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients

  2005cites this paper
• Adverse effect of polyvalent immunoglobulin in the treatment of Guillain-Barre syndrome.

  2003cites this paper
• Immunomodulatory action of intravenous immunoglobulin

  2002cites this paper
• Autoantibodies to factor VIII.

  2002cites this paper
• Opsoclonus-Myoclonus Syndrome in Childhood

  2002cites this paper
• Immunomodulation of Autoimmunity by Intravenous Immunoglobulin through Interaction with Immune Networks

  2002cites this paper
• Antifibroblast antibodies from systemic sclerosis patients are internalized by fibroblasts via a caveolin-linked pathway.

  2002cites this paper
• Anti-fibroblast antibodies in systemic sclerosis.

  2002cites this paper
• Wirkmechanismen von Immunglobulinen

  2001cites this paper
• IVIg inhibits reticuloendothelial system function and ameliorates murine passive‐immune thrombocytopenia independent of anti‐idiotype reactivity

  2001influential citation
• Can intravenous immunoglobulin improve antibody‐mediated botulinum toxin therapy failure?

  2000cites this paper
• Lack of association between cytochrome P450 2E1 gene polymorphisms and Parkinson's disease in a Chinese population

  2000cites this paper
• Neuroacanthocytosis presenting as Parkinsonism

  2000cites this paper
• Pseudoathetosis in a patient with cervical myelitis: Neurophysiologic and functional MRI studies

  2000cites this paper
• Suppression of experimental autoimmune encephalomyelitis by intravenously administered polyclonal immunoglobulins.

  2000cites this paper
• Hyperekplexia in the first year of life

  2000cites this paper
• Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders

  1999cites this paper
• Effets immunomodulateurs des immunoglobulines intraveineuses au cours des maladies auto-immunes

  1999cites this paper
• Immunomodulation of Autoimmune Disease with Normal Polyspecific Immunoglobulin G (Intravenous Immunoglobulin)

  1999cites this paper
• Mechanisms of Action of Intravenous Immunoglobulin (IVIg) in Immune-Mediated Diseases

  1999cites this paper
• Natural anti-endothelial cell antibodies (AECA).

  1999cites this paper
• Anti‐idiotypic antibodies to anti–PDC‐E2 in primary biliary cirrhosis and normal subjects

  1999cites this paper
• [Immunomodulatory effects of intravenous immunoglobulins in autoimmune diseases].

  1999cites this paper
• Intravenous immunoglobulin treatment of neurological autoimmune diseases.

  1998cites this paper
• Utilisation thérapeutique des immunoglobulines polyvalentes en hématologie

  1998cites this paper
• Anti-Idiotypes to Autoantibodies in Therapeutic Preparations of Normal Polyspecific Human IgG (Intravenous Immunoglobulin, IVIg)

  1997cites this paper
• Human immunoglobulin ameliorates rat experimental autoimmune neuritis.

  1997cites this paper
• Intravenous Immune Globulin for Inducing Remissions in Systemic Lupus Erythematosus

  1997cites this paper
• Antiendothelial cell antibodies (AECA) in systemic lupus erythematosus (SLE)

  1997cites this paper
• Mechanisms of action of intravenous immune globulin in immune‐mediated diseases

  1996cites this paper
• Quantitative analysis of multiple V‐region interactions among normal human IgG

  1996cites this paper
• [Anti-GM1 gangliosides antibodies in multifocal motor neuropathies].

  1996cites this paper
• Therapie mit Immunglobulinen bei neurologischen Autoimmunerkrankungen

  1995cites this paper
• [Therapy with immunoglobulins in neurologic autoimmune diseases. Indications and mechanism of action].

  1995cites this paper
• Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin.

  1995cites this paper
• Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases.

  1994cites this paper
• Immunomodulating effects of intravenous immunoglobulin in autoimmune and inflammatory diseases.

  1994cites this paper
• V Region‐Mediated Selection of Autoreactive Repertoires by Intravenous Immunoglobulin (i.v.Ig)

  1994influential citation
• Observations on the Mode of Action of Normal Immunoglobulin at High Doses

  1994cites this paper
• IMMUNOMODULATION OF AUTOIMMUNE AND SYSTEMIC INFLAMMATORY DISEASES WITH INTRAVENOUS IMMUNOGLOBULIN

  1994cites this paper
• Mécanismes d'action des immunoglobulines intraveineuses dans le traitement des maladies auto-immunes et inflammatoires

  1994cites this paper
• Treatment of autoimmune diseases with normal immunoglobulin through manipulation of the idiotypic network

  1993cites this paper